BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Drug Development

  Phase I/II Clinical Trial Results Positive for SpinalCyte’s CybroCell Dermal Fibroblasts

  SpinalCyte’s Phase 1/2 trial is the first allogeneic use of fibroblasts outside of skin conditions.

  February 13, 2018

   · 

  4 min read
• Business

  MOLOGEN Signs License Deal for China and Global Co-Development Agreement with ONCOLOGIE for Lead Compound lefitolimod

  MOLOGEN announced today the signing of a license deal for the Chinese territory and a global co-development agreement between MOLOGEN and ONCOLOGIE Inc. for its lead compound lefitolimod.

  February 13, 2018

   · 

  6 min read
• Genetown

  BC Platforms to Provide Real World Evidence Solutions to Pfizer in Cardiovascular Diseases

  BC Platforms today announces that Pfizer Finland will be using its technology solutions and research platform, including BCRQUEST.COM, to study data in cardiovascular diseases.

  February 13, 2018

   · 

  1 min read
• Business

  Digirad Corporation to Release 2017 Fourth Quarter and Year-End Financial Results on February 23, 2018

  A conference call is scheduled for 11:00 a.m. EST (8:00 a.m. PST) on February 23, 2018 to discuss the results and management’s outlook. The call may be accessed by dialing 1-877-407-9039 (international callers +1-201-689-8470).

  February 13, 2018

   · 

  3 min read
• GN Store Nord: Transactions in Relation to Share Buyback Program – Feb. 13, 2018

  The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

  February 13, 2018

   · 

  2 min read
• Biotage Release: New ISOLUTE HYDRO DME+ Rapidly Removes Matrix Interferences From Urine

  Biotage is pleased to announce the launch of ISOLUTE HYDRO DME+ fixed well plates and columns, for the efficient removal of matrix components from urine, using a simple pass through workflow.

  February 13, 2018

   · 

  1 min read
• Drug Development

  ERYTECH Selects Triple Negative Breast Cancer as Next Indication for Eryaspase

  Following these very encouraging results, ERYTECH conducted a comprehensive evaluation to determine other potential solid-tumor indications for developing eryaspase.

  February 13, 2018

   · 

  8 min read
• Biotech Beach

  MediciNova Announces Closing of Underwritten Public Offering of Common Stock

  In addition, MediciNova has granted the underwriters a 30-day option to purchase up to an additional 662,983 shares of common stock at the public offering price, less underwriting discounts and commissions.

  February 13, 2018

   · 

  6 min read
• Business

  SCORR Marketing and Applied Clinical Trials Release Survey Report on Patient Engagement

  The survey, conducted in partnership with Applied Clinical Trials, was undertaken to shed light on how life science companies can improve patient engagement initiatives and, ultimately, patient participation and retention in clinical trials.

  February 13, 2018

   · 

  2 min read
• Business

  Sobi Names Linea Aspesi Vice President of Human Resources in North America

  Sobi announced today the appointment of Linea Aspesi as vice president of human resources for North America.

  February 13, 2018

   · 

  2 min read